CNH Partners »

Cerevel Therapeutics Hldng I shares owned by CNH Partners

Quarter-by-quarter ownership of Cerevel Therapeutics Hldng I (CERE) shares owned by CNH Partners from 13F filings

Historical chart of CNH Partners investment in Cerevel Therapeutics Hldng I

Tip: Access up to 7 years of quarterly data

All positions including Cerevel Therapeutics Hldng I held by CNH Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Cerevel Therapeutics Hldng I by CNH Partners

Quarter filed Position value Share count Share price at filing
2023-12-31 $40M 934k 42.40

More positions owned by CNH Partners

Karuna Therapeutics Ord
Splunk Note 1.125% 6/1 (Principal)
ImmunoGen
Albertsons Cos Common Stock (ACI)
Cerevel Therapeutics Hldng I (CERE)
United States Steel Corporation (X)
Wayfair Note 3.250% 9/1 (Principal)
PNM Resources (PNM)
Etsy Note 0.250% 6/1 (Principal)
Amedisys (AMED)
Array Technologies Note 1.000%12/0 (Principal)
Gores Holdings Ix Class A Com (GHIX)
Hess (HES)
Lci Inds Note 1.125% 5/1 (Principal)
Pioneer Natural Resources (PXD)

View all positions for CNH Partners

Top funds holding Cerevel Therapeutics Hldng I

Perceptive Advisors
venBio Select Advisor
Vanguard Group
Paradigm Biocapital Advisors
Balyasny Asset Management
Alpine Associates Management
Baker Bros. Advisors
Alliancebernstein
Millennium Management
Pentwater Capital Management
CNH Partners
Westchester Capital Management
Voloridge Investment Management
Westfield Capital Management Company
T. Rowe Price Associates

View all funds holding Cerevel Therapeutics Hldng I